0001104659-24-031942.txt : 20240307 0001104659-24-031942.hdr.sgml : 20240307 20240307170207 ACCESSION NUMBER: 0001104659-24-031942 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240305 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rajah Vignesh CENTRAL INDEX KEY: 0001815042 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38650 FILM NUMBER: 24731097 MAIL ADDRESS: STREET 1: HENRIKSHOJ 8 STREET 2: ROOM 4 CITY: VEDBAEK STATE: G7 ZIP: DK-2950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc. CENTRAL INDEX KEY: 0001722964 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474619612 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 3350 CITY: NEW YORK STATE: NY ZIP: 10169 BUSINESS PHONE: 212-847-9841 MAIL ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 3350 CITY: NEW YORK STATE: NY ZIP: 10169 4 1 tm248257-3_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-05 0 0001722964 Y-mAbs Therapeutics, Inc. YMAB 0001815042 Rajah Vignesh C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, SUITE 3350 NEW YORK NY 10169 0 1 0 0 SVP & CHIEF MEDICAL OFFICER 0 Common Stock 2024-03-05 4 S 0 1711 16.53 D 33889 D Common Stock 4266 I By Spouse and minor Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units. This transaction was executed in multiple trades at prices ranging from $16.52 to $16.555, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 4,033 shares of common stock owned by Reporting Person's spouse and 233 held by Reporting Person's minor child. Reporting Person may be deemed to have a pecuniary interest in the securities due to family relationship. Reporting Person disclaims beneficial ownership of the securities reported and this report shall not be deemed an admission that Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act, as amended, or for any other purpose. /s/ John LaRocca, Attorney-in-Fact 2024-03-07